Table 1.
Characteristics of patients in the Pre- and Post-Implementation Cohorts
| Patient Characteristics | Pre N= 3713 (%) |
Post N= 4761 (%) |
p value* |
|---|---|---|---|
| Age –median (IQR) | 54 (45, 65) | 54 (44, 66) | 0.330 |
| Female | 1965 (52.9) | 2579 (54.1) | 0.278 |
| Race | 0.038 | ||
| White or Caucasian | 2484 (66.9) | 3106 (65.2) | |
| Black or African American | 1052 (28.3) | 1371 (28.8) | |
| Other | 177 (4.8) | 284 (6.0) | |
| Ethnicity | 0.006 | ||
| Hispanic or Latino | 134 (3.6) | 230 (4.8) | |
| Site | <0.001 | ||
| WFBMC | 2720 (73.3) | 3685 (77.4) | |
| DMC | 396 (10.7) | 512 (10.8) | |
| LMC | 597 (16.1) | 564 (11.8) | |
| Insurance Status | 0.054 | ||
| Blue Cross | 790 (21.3) | 970 (20.4) | |
| MedCost | 209 (5.6) | 286 (6.0) | |
| Medicaid | 505 (13.6) | 687 (14.4) | |
| Medicare | 1189 (32.0) | 1617 (34.0) | |
| Other insurance | 321 (8.6) | 413 (8.7) | |
| Self-pay | 699 (18.8) | 788 (16.5) | |
| EHR ACS flowsheet used | 137 (3.7) | 1033 (21.7) | <0.001 |
| Risk Factors | |||
| Prior CAD | 1036 (27.9) | 1280 (26.9) | 0.297 |
| Diabetes | 1031 (27.8) | 1290 (27.1) | 0.491 |
| Hyperlipidemia | 1528 (41.2) | 1993 (41.9) | 0.512 |
| Hypertension | 2406 (64.8) | 2986 (62.7) | 0.048 |
| Smoking | 2356 (63.5) | 2878 (60.5) | 0.005 |
| BMI ≥30 | 1694 (45.6) | 2198 (46.1) | 0.302 |
| Peripheral Vascular Disease | 450 (12.1) | 635 (13.3) | 0.096 |
| Cerebrovascular Disease | 456 (12.2) | 594 (12.5) | 0.787 |
| Comorbidities | |||
| COPD | 1173 (31.6) | 1543 (32.4) | 0.424 |
| Cancer | 570 (15.4) | 746 (15.7) | 0.689 |
| Chronic Kidney Disease | 416 (11.2) | 576 (12.1) | 0.204 |
*
Chi-squared tests were used for categorical variables and Wilcoxon rank-sum tests were used for continuous variables. IQR= Interquartile range, WFBMC= Wake Forest Baptist Medical Center, DMC= Davie Medical Center, LMC= Lexington Medical Center. CAD= Coronary Artery Disease, BMI= Body Mass Index, COPD = Chronic Obstructive Pulmonary Disease